Management of anxiety and sleep disorders: Role of complementary and alternative medicine and challenges of integration with conventional orthodox care

Martins Ekor; Oluyomi S. Adeyemi; Chiagoziem A. Otuechere

doi:10.1007/s11655-013-1197-5

Your Location：

Home >

Browse articles >

Management of anxiety and sleep disorders: Role of complementary and alternative medicine and challenges of integration with conventional orthodox care

OriginalPaper | Updated：2021-08-27

- Management of anxiety and sleep disorders: Role of complementary and alternative medicine and challenges of integration with conventional orthodox care
- Management of anxiety and sleep disorders: Role of complementary and alternative medicine and challenges of integration with conventional orthodox care
- 中国结合医学杂志（英文版） 2013年19卷第1期页码：5-14
- Affiliations：
  
  1. Department of Pharmacology, School of Medical Sciences, University of Cape Coast, Cape Coast,Ghana
  2. Department of Chemical Sciences, Redeemer’s University, Ogun State,Nigeria
- Author bio：
- Funds：
- DOI：10.1007/s11655-013-1197-5
  中图分类号：
- 纸质出版日期：2013，
  
  网络出版日期：2012-12-29，
Scan for full text
Ekor, M., Adeyemi, O.S. & Otuechere, C.A. Management of anxiety and sleep disorders: Role of complementary and alternative medicine and challenges of integration with conventional orthodox care., Chin. J. Integr. Med. 19, 5–14 (2013). https://doi.org/10.1007/s11655-013-1197-5

Martins Ekor, Oluyomi S. Adeyemi, Chiagoziem A. Otuechere. Management of anxiety and sleep disorders: Role of complementary and alternative medicine and challenges of integration with conventional orthodox care[J]. Chinese Journal of Integrative Medicine, 2013,19(1):5-14.
Ekor, M., Adeyemi, O.S. & Otuechere, C.A. Management of anxiety and sleep disorders: Role of complementary and alternative medicine and challenges of integration with conventional orthodox care., Chin. J. Integr. Med. 19, 5–14 (2013). https://doi.org/10.1007/s11655-013-1197-5 DOI：

Martins Ekor, Oluyomi S. Adeyemi, Chiagoziem A. Otuechere. Management of anxiety and sleep disorders: Role of complementary and alternative medicine and challenges of integration with conventional orthodox care[J]. Chinese Journal of Integrative Medicine, 2013,19(1):5-14. DOI： 10.1007/s11655-013-1197-5.

摘要

There is renewed attention and greater focus on anxiety and sleep- sleep-related disturbances because of the high prevalence

complexity

and their health related implications. The role of complementary and alternative medicine (CAM)

which refers to therapeutic approaches that are “complementary to the end goals of decreasing illness and enhancing wellness

but are alternative to conventional medical treatment” is also increasingly recognized. In this review

we considered CAM approach to the management of anxiety and sleep disorders and discussed a few challenges associated with the effective integration of alternative therapy with conventional orthodox medical care.

Abstract

There is renewed attention and greater focus on anxiety and sleep- sleep-related disturbances because of the high prevalence

complexity

and their health related implications. The role of complementary and alternative medicine (CAM)

which refers to therapeutic approaches that are “complementary to the end goals of decreasing illness and enhancing wellness

but are alternative to conventional medical treatment” is also increasingly recognized. In this review

关键词

anxietysleep disorderscomplementary and alternative therapyorthodox treatment

Keywords

anxietysleep disorderscomplementary and alternative therapyorthodox treatment

references

Gregory AM, Caspi A, Eley TC, Moffitt TE, Oconnor TG, Poulton R. Prospective longitudinal associations between persistent sleep problems in childhood and anxiety and depression disorders in adulthood. J Abnormal Child Psychology 2005;33:157–163.

Kessler RC, Berglund P, Demler O, Jin R, Merikangas KR, Walters EE. Lifetime prevalence and age of onset distributions of DSM-IV disorders in the National Comorbidity Survey replication. Arch Gen Psychiatry 2005;62:593–602.

Ramsawh HJ, Stein MB, Belik SL, Jacobi F, Sareen J. Relationship of anxiety disorders, sleep quality, and functional impairment in a community sample. J Psychiatry Res 2009;43:926–933.

Marcks BA, Weisberg RB, Edelen MO, Keller MB. The relationship between sleep disturbance and the course of anxiety disorders in primary care patients. Psychiatry Res 2010;178:487–492.

Mellman TA. Sleep and anxiety disorders. Psych Clin North Am 2006;29:1047–1058.

Leger D, Poursain B. An international survey of insomnia: underrecognition and under-treatment of a polysymptomatic condition. Curr Med Res Opin 2005;21:1785–1795.

Hirschfeld RM. The comorbidity of major depression and anxiety disorders: recognition and management in primary care. Prim Care Companion J Clin Psychiatry 2001;3:244–254.

Tyrer P, ed. A multidisciplinary review. London: Imeprial College Press; 1999:222–253.

Blazer DG, Hughes DC, George LK. Generalized anxiety disorder. In: Bobus LN, Regier DA, eds. Psychiatric disorders in America: the epidemiological catchments area study. New York: Fress Press; 1991:180–203.

Cohn JB, Bowden CL, Fishers JG. Double blind comparison of buspirone and clorazepate in anxious outpatients. Am J Med 1986;80(Suppl):10–16.

Dubovsky SL, Thomas M. Serotonergic mechanisms and current and future psychiatric practice. J Clin Psychopharm 1995;10(Suppl):26–30.

Young T, Peppard PE, Gottlieb DJ. Epidemiology of obstructive sleep apnea: a population health perspective. Am J Respir Crit Care Med 2002;165:1217–1239.

American Academy of Sleep Medicine. International classification of sleep disorders. 2nd ed. Diagnostic and coding manual. Westchester IL, American Academy of Sleep Medicine; 2005.

National Institute of Health. National center on sleep disorderresearch. 2003. www.nhlbi.nih.gov/health/prof/sleep/res_plan/sleep-rplan.

Grustein R. Insomnia: diagnosis and management. Aust Fam Phys 2002;31:995–1000.

Bloom HG, Ahmed I, Alessi CA, Ancoli-Israel S, Buysse DJ, Kryger MH, et al. Evidence-based recommendations for the assessment and management of sleep disorders in older persons. J Am Geriatr Soc 2009;57:761–789.

Reid KJ, Martinovich Z, Finkel S, Statsinger J, Golden R, Harter K, et al. Sleep: a marker of physical andmental health in the elderly. Am J Geriatr Psychiatry 2006;14:860–866.

Vaz Fragoso CA, Gill TM. Sleep complaints in community-living older persons: a multifactorial geriatric syndrome. J Am Geriatr Soc 2007;55:1853–1866.

Taylor DJ, Mallory LJ, Lichstein KL, Durrence HH, Riedel BW, Bush AJ. Comorbidity of chronic insomnia with medical problems. Sleep 2007;30:213–218.

Foley D, Ancoli-Israel S, Britz P, Walsh J. Sleep disturbances and chronic disease in older adults: results of the 2003 National Sleep Foundation Sleep in America Survey. J Psychosom Res 2004;56:497–502.

NCCAM Clearinghouse. General information about CAM and the NCCAM. 2002. Available at http://nccam.nih.gov/health/whatiscam/#1.

Starr P. The social transformation of American medicine. San Francisco, Calif: Harper Collins Publishers; 1982:514.

Astin JA. Why patients use alternative medicine: results of a national study. JAMA 1998;279:1548–1553.

Eisenberg DM, Davis RB, Ettner SL, Appel S, Wilkey S, van Rompay M, et al. Trends in alternative medicine use in the United States, 1990–1997: results of a follow-up national survey. JAMA 1998;280:1569–1575.

Chez IRA, Jonas WB. The challenge of complementary and alternative medicine. Am J Obstet Gynecol 1997;177:1156–1161.

Buscemi N, Vandermeer B, Pandya R, Hooton N, Tjosvold L, Hartling L, et al. Melatonin for treatment of sleep disorders. Evid Rep Technol Assess (Summ) 2004;108:1–7.

Durham RC, Fisher PL, Dow MGT, Sharp D, Power KG, Swan JS, et al. Cognitive behaviour therapy for good and poor prognosis generalized anxiety disorder: a clinical effectiveness study. Clin Psychol Psychother 2004;11:145–157.

Monti JM, Monti D. Sleep disturbance in generalized anxiety disorder and its treatment. Sleep Med Rev 2000;4:263–276.

Reite M, Ruddy J, Nagel K, eds. Evaluation and management of sleep disorders. 3rd ed. Washington, DC: American Psychiatric Publishing, Inc.; 2002:32–44.

Wagner DR. Circadian rhythm sleep disorders. In: Thorpy MJ, ed. Handbook of sleep disorders. New York: Dekker; 1990:493–525.

Czeisler CA, Kronauer RE, Allan JS, Duffy JF, Jewett ME, Brown EN, et al. Bright light induction of strong (type 0) resetting of the human circadian pacemaker. Science 1989;244:1328–1333.

Cole RJ, Smith JS, Alcala YC, Elliot JA, Kripke DF. Brightlight mask treatment of delayed sleep phase syndrome. J Biol Rhythms 2002;17:89–101.

Lack L, Wright H. The effect of evening bright light in delaying the circadian rhythms and lengthening the sleep of early morning awakening insomniacs. Sleep 1993;16:436–443.

Campbell SS, Dawson D, Anderson MW. Alleviation of sleep maintenance insomnia with timed exposure to bright light. J Am Geriatr Soc 1993;41:829–836.

Zeitzer JM, Dijk DJ, Kronauer R, Brown E, Czeisler C. Sensitivity of the human circadian pacemaker to nocturnal light: melatonin phase-resettng and suppression. J Physiol 2000;526(Pt 2):695–702.

Khalsa SB, Jewett ME, Cajochen C, Czeisler CA. A phase response curve to single bright light pulses in human subjects. J Physiol 2003;549(Pt 3):945–952.

Mendelson WB, Jain B. An assessment of short-acting hypnotics. Drug Saf 1995;13:257–270.

Attele AS, Xie JT, Yuan CS. Treatment of insomnia: an alternative approach. Attern Med Rev 2000;249–259.

Gordon N. The therapeutics of melatonin: a paediatric perspective. Brain Dev 2000;22:213–217.

Leone RM, Silman RE. Melatonin can be differentially metabolized in the rat to produce N-acetylserotonin in addition to 6-hydroxymelatoni. Endocrinology 1984;114:1825–1832.

Young IM, Leone RM, Francis P, Stovell P, Silman RE. Melatonin is metabolized to nacetyl serotonin and 6-hydroxymelatonin in man. J Clin Endocrinol Metab 1985;60:114–119.

Vijayalaxmi, Thomas Jr CR, Reiter RJ, Herman TS. Melatonin: from basic research to cancer treatment clinics. J Clin Oncol 2002;20:2575–2601.

Folkard S, Arendt J, Clark M. Can melatonin improve shift workers’ tolerance of the night shift? Some preliminary findings. Chronobiol Int 1993;10:315–320.

Garfunkel D, Laundon M, Nof D, Zisapel N. Improvement of sleep quality in elderly people by controlled release of melatonin. Lancet 1990;346:541–543.

Haimov I, Laudon M, Zisapel N, Souroujon M, Nof D, Shlitner A, et al. Sleep disorders and melatonin rhythms in elderly people. Br Med J 1994;309:167.

Walsh JK, Benca RM, Bonnet M, Buysee DJ. Insomnia: assessment and management in primary care. Am Fami Physician 1999;59:3029–3038.

Kumar V. Potential medicinal plants for CNS disorders: an overview. Phytother Res 2006;20:1023–1035.

Teschke R, Qiu SX, Lebot V. Herbal hepatotoxicity by Kava: update on piper methystine, flavokavain B and mould hepatotoxins as primarily assumed culprits. Dig Liver Dis 2011;43:676–681.

Pittler MH, Ernst E. Pittler, Max H, eds. Kava extract for treating anxiety. Cochrane database of systematic reviews (Online) 2003;(1):CD003383.

Thompson R, Ruch W, Hasenöhrl RU. Enhanced cognitive performance and cheerful mood by standardized extracts of Piper methysticum (Kava-kava). Hum Psychopharmacol 2004;19:243–250.

Sorrentino L, Capasso A, Schmidt M. Safety of ethanolic Kava extract: results of a study of chronic toxicity in rats. Phytomedicine 2006;13:542–549.

Cairney S, Maruff P, Clough AR. The neurobehavioural effects of Kava. Aust New Zealand J Psychiatry 2002;36:657–652.

Hunter A. Kava (Piper methysticum) back in circulation. Aust Centre Complement Med 2006;25:529.

Fu PP, Xia Q, Guo L, Yu H, Chan PC. Toxicity of Kava kava. J Environ Sci Health C Environ Carcinog Ecotoxicol Rev 2008;26:89–112.

Mennini T, Bernasconi P, Bombardelli E, Morazzoni P. In vitro study in the interaction of extracts and pure compounds from Valerian officinalis roots with GABA, benzodiazepine and barbiturate receptors. Fitoterapia 1993;64:291–300.

Shahidi F, Naczk M, eds. Phenolics in food and nutraceuticals. Boca Raton, Florida, USA: CRC Press; 2004:313–314.

Yuan CS, Mehendale S, Xiao Y, Aung HH, Xie JT, Ang-Lee MK. The gamma-aminobutyric acidergic effects of valerian and valerenic acid on rat brainstem neuronal activity. Anesth Analg 2004;98:353–358.

Wills RBH, Shohet D. Changes in valerenic acids content of valerian root (Valeriana officinalis L.) during long-term storage. Food Chemistry 2009;115:250–253.

Marder M, Viola H, Wasowski C, Fernández S, Medina JH, Paladini AC. 6-methylapigenin and hesperidin: new valeriana flavonoids with activity on the CNS. Pharmacol Biochem Behav 2003;75:537–545.

Fernández S, Wasowski C, Paladini AC, Marder M. Sedative and sleep-enhancing properties of linarin, a flavonoidisolated from Valeriana officinalis. Pharmacol Biochem Behav 2004;77:399–404.

Holzl J, Godau P. Receptor binding studies with Valeriana officinalis on the benzodiazepine receptor. Planta Medica 1989;55:642.

Lacher SK, Mayer R, Sichardt K, Nieber K, Müller CE. Interaction of valerian extracts of different polarity with adenosine receptors: identification of isovaltrate as an inverse agonist at A1 receptors. Biochem Pharmacol 2007;73:248–258.

National Institute of Mental Health. Treatment of anxiety disorders. 2006. Available at http://www.nimh.nih.gov/publicat/anxiety.cfm#anx9.

Klepser TB, Klepser ME. Unsafe and potentially safe herbal therapies. Am J Health-Syst Pharm 1999;56:125–138.

Miller LG. Herbal medicines. Selected clinical considerations focusing on known or potential drug-herb interactions. Arch Intern Med 1998;15:2200–2211.

Wong AHC, Smith M, Boon HS. Herbal remedies in psychiatric practice. Arch Gen Psychiatry 1998;55:1033–1044.

MacGregor FB, Abernethy VE, Dahabra S, Cobden I, Hayes PC. Hepatotoxicity of herbal remedies. Br Med J 1989;299:1156–1157.

Garges HP, Varia I, Doraiswamy PM. Cardiac complications and delirium associated with valerian root withdrawal. JAMA 1998;280:1566–1567.

Akhondzadeh S, Naghavi HR, Vazirian M, Shayegapour A, Rahidi H, Khani M. Passionflower in the treatment of generalized anxiety: a pilot double-blind randomized controlled trial with oxazepam. J Clin Pharm Ther 2001;26:363–367.

Barrett B. Alternative, complementary, and conventional medicine: is integration upon us? J Altern Complement Med 2003;9:417–427.

Markman M. Safety issues in using complementary and alternative medicine. J Clin Oncol 2002;20:39s–41s.

Ang-Lee MK, Moss J, Wuan CS. Herbal medicines and perioperative care. J Am Med Assoc 2001;286:208–216.

Piscitelli S. Preventing dangerous drug interactions. J Am Pharm Assoc 2000;40(5 Suppl 1):S44–S45.

Piscitelli SC, Burstein AH, Chaitt D. Endinavir concentrations and St. John’s Wort. Lancet 2002;255:547–550.

Cohen MH, Eisenberg DM. Potential physician malpractice liability associated with complementary and integrative medical therapies. Ann Intern Med 2002;136:596–603.

White AR, Ernst E. Economic analysis of complementary medicine: a systematic review. Complement Ther Med 2000;8:111–118.

Caspi OL, Sechrest L, Pitluk HC, Marshall CL, Bell IR, Nichter M. On the definition of complementary, alternative and integrative medicine: societal mega stereotypes vs. the patients’ perspective. Altern Ther Health Med 2003;9:58–62.

Mann JD, Gaylord SA, Norton SK. Integrating complementary and alternative therapies with conventional care (The convergence of complementary, alternative and conventional health care: educational resources for health professionals). University of North Carolina at Chapel Hill, Program on Integrative Medicine, 2004:25–28. Avaible at http//www.med.unc.edu/phyrehab/pim/files/Integrating.pdf

Cassell EJ. The nature of suffering and the goals of medicine. New Engl J Med 1982;306:639–645.

Snyderman R, Weil A. Integrative medicine. Arch Intern Med 2002;162:395–397.

Furnham A. Why do people choose and use complementary therapies? In: Ernst E, ed. Complementary medicine: an objective appraisal. Oxford: Butterworth-Heinemann; 1996:71–88.

Beyth RJ, Shorr RI. Epidemiology of adverse drug reactions in the elderly by drug class. Drugs Aging 1999;3:231–239.

Bretherton A, Day L, Lewis G. Polypharmacy and older people. Nursing Times 2003;17:54–55.

Colley CA, Lucas LM. Polypharmacy: the cure becomes the disease. J Gen Intern Med 1993;5:278–283.

Enqvist B, Fischer K. Preoperative hypnotic techniques reduce consumption of analgesics after surgical removal of third mandibular molars. Int J Clin Exp Hypn 1997;45:102–108.

Somri MS, Vaida SJ, Sabo E, Yassain G, Gankin I, Gaitini LA. Acupuncture versus ondansetron in the prevention of postoperative vomiting. A study of children undergoing dental surgery. Anaesthesia 2001;56:927–932.

Kessler RC, Davis RB, Foster DF, Van Rompay MI, Walters EE, Wilkey SA, et al. Long-term trends in the use of complementary and alternative medical therapies in the United States. Ann Intern Med 2001;136:262–268.

Faass N, ed. Integrating complementary medicine into health systems. Gaithersburg, MD: Aspen Publications; 2001:76–89.

White House Commission on Complementary and Alternative Medicine Policy. Final Report. Health and Human Services, August 11, 2002. Available at http://www.whccamp.hhs.gov/finalreport.html.

Cohen MH. Legal issues in complementary and integrative medicine: a guide for the clinician. Med Clin North Am 2002;86:185–196.

FULL TEXT LINK

More>

浏览量

850

Downloads

CSCD

文章被引用时，请邮件提醒。

Submit

工具集

关联资源

Complementary and alternative medicine in rheumatoid arthritis

Progressive Muscle Relaxation Combined with Chinese Medicine Five-Element Music on Depression for Cancer Patients: A Randomized Controlled Trial